1.Expression of p21(waf1/cip1) Protein in Bladder Cancer and its Prognostic Value.
Hwal LEE ; Houng Gyu SOHN ; Dal Bong HA ; Ki Kwon KIM ; Kyung Seop LEE
Korean Journal of Urology 2000;41(7):826-832
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
2.Intravesical Therapy for Superficial Bladder Cancer: Advances and Future.
Korean Journal of Urology 2000;41(4):467-479
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
3.T1 bladder tumor: a heterogeneous and potentially dangerous group.
Journal of the Korean Cancer Association 1991;23(4):843-852
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
4.Detecting Malignant Urothelial Cells by Morphometric Analysis of ThinPrep(R) Liquid-based Urine Cytology Specimens.
Bong Kyung SHIN ; Young Suk LEE ; Hoiseon JEONG ; Sang Ho LEE ; Hyunchul KIM ; Aree KIM ; Insun KIM ; Han Kyeom KIM
Korean Journal of Cytopathology 2008;19(2):136-143
Urothelial carcinoma accounts for 90% of all the cases of bladder cancer. Although many cases can be easily managed by local excision, urothelial carcinoma rather frequently recurs, tends to progress to muscle invasion, and requires regular follow-ups. Urine cytology is a main approach for the follow-up of bladder tumors. It is noninvasive, but it has low sensitivity of around 50% with using the conventional cytospin preparation. Liquid-based cytology (LBC) has been developed as a replacement for the conventional technique. We compared the cytomorphometric parameters of ThinPrep(R) and cytospin preparation urine cytology to see whether there are definite differences between the two methods and which technique allows malignant cells to be more effectively discriminated from benign cells. The nuclear-to-cytoplasmic ratio value, as measured by digital image analysis, was efficient for differentiating malignant and benign urothelial cells, and this was irrespective of the preparation method and the tumor grade. Neither the ThinPrep(R) nor the conventional preparation cytology was definitely superior for distinguishing malignant cells from benign cells by cytomorphometric analysis of the adequately preserved cells. However, the ThinPrep(R) preparation showed significant advantages when considering the better preservation and cellularity with a clear background.
Muscles
;
Urinary Bladder Neoplasms
5.Comparison of the Bard BTA stat test, Bard BTA test, NMP-22 test and Cytology in the Diagnosis of Bladder Cancer.
Jeong Soo KIM ; Hyun Mu LEE ; Kang Hyun LEE
Korean Journal of Urology 2000;41(7):833-837
No abstract available.
Diagnosis*
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
6.Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8).
Sun Ok SONG ; Kwang Joon KIM ; Byung Wan LEE
Diabetes & Metabolism Journal 2012;36(6):462-463
No abstract available.
Thiazolidinediones
;
Urinary Bladder
;
Urinary Bladder Neoplasms
8.Significance of T1 Substaging on the Recurrence and Progression of Bladder Cancer.
Yong Jae KIM ; Kyung Hyun MOON ; Kyu Rae KIM ; Choung Soo KIM
Korean Journal of Urology 2000;41(11):1323-1328
No abstract available.
Recurrence*
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
9.Prognostic indexes in patients treated with intravesical bacillus calmette-guerin for superficial bladder cancer.
Choal Hee PARK ; Chun Il KIM ; Sung Choon LEE
Journal of the Korean Cancer Association 1991;23(4):835-842
No abstract available.
Bacillus*
;
Humans
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
10.Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8).
Kwang Joon KIM ; Sun Ok SONG ; Byung Wan LEE
Diabetes & Metabolism Journal 2013;37(1):83-84
No abstract available.
Thiazolidinediones
;
Urinary Bladder
;
Urinary Bladder Neoplasms
Result Analysis
Print
Save
E-mail